KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Shares Outstanding (Diluted Average) (2016 - 2026)

Globus Medical filings provide 13 years of Shares Outstanding (Diluted Average) readings, the most recent being $137.1 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 0.59% to $137.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $137.1 million, a 0.59% decrease, with the full-year FY2025 number at $137.1 million, down 0.59% from a year prior.
  • Shares Outstanding (Diluted Average) hit $137.1 million in Q4 2025 for Globus Medical, down from $137.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $137.9 million in Q4 2024 to a low of $114.6 million in Q4 2023.
  • Median Shares Outstanding (Diluted Average) over the past 3 years was $137.1 million (2025), compared with a mean of $129.8 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 20.27% in 2024 and later fell 0.59% in 2025.
  • Globus Medical's Shares Outstanding (Diluted Average) stood at $114.6 million in 2023, then rose by 20.27% to $137.9 million in 2024, then dropped by 0.59% to $137.1 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $137.1 million (Q4 2025), $137.9 million (Q4 2024), and $114.6 million (Q4 2023) per Business Quant data.